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Some things just go well together.
During the day, our waking
activities — walking and running,
eating and gesturing — entail large,
coordinated muscle movements and
supportive postural muscle tone,
typically accompanied by a general
awareness of what we are doing.
Conversely, at night as we sleep, we
are immobile, our muscle tone is low
or absent, and we are largely unaware
of our surroundings. And so go our
lives, at least for most of us. But for
some of us, our motor and cognitive
experiences can become uncoupled in
odd, often disturbing, and sometimes
dangerous ways: we might walk in our
sleep (somnambulism), wake up
paralyzed in a semi-conscious state
(sleep paralysis), seemingly ‘act out
our dreams’ in ways that can endanger
the dreamer and his/her bedroom
companion (REM sleep behavior
disorder), or suddenly lose all muscle
tone and collapse to the ground,
functionally paralyzed yet completely
aware of what is happening in the
immediate environment (cataplexy) [1].
Such disorders blur the boundaries
between sleep and wake states,
revealing inadequacies in the language
we use to describe them. But this
blurring also inspires and focuses our
search for biological mechanisms.
For those perplexed by the decoupling
of muscle tone and arousal that
characterizes cataplexy, a beautiful
new study reported in this issue of
Current Biology by Burgess and Peever
[2] offers several clarifying insights.
Cataplexy is one of the prominent
symptoms of narcolepsy, a
neurodegenerative disorder that is also
characterized by excessive daytime
sleepiness [1]. In one of the great
success stories of modern
neuroscience [3], the co-discovery in
the late-1990s [4,5] of a new
neurotransmitter, called hypocretin(or orexin), led rapidly to the realization
that this neurotransmitter is intimately
connected with narcolepsy in dogs [6]
and humans [7,8]. In short order,
hypocretin knockout mice were
developed and found to exhibit many
of the features of human narcolepsy,
including cataplexy [9,10].
The loss of muscle tone during
cataplexy resembles the loss of tone
that normally occurs during rapid
eye movement (REM) sleep. This
observation implicates those brain
structures that control or mediate
effects on sleep-wake activity and
muscle tone. One potential candidate is
the locus coeruleus, a dense collection
of neurons in the midbrain that is a
major source of noradrenaline
throughout the brain (Figure 1). It has
been known for many years that
neurons in the locus coeruleus are
most active during waking, less
active during quiet sleep, and nearly
silent during REM sleep [11],
mirroring changes in muscle tone
across those states. Locus coeruleus
neurons also cease their activity
during cataplectic episodes [12],
just as they do during REM sleep.
Moreover, anatomical connections
between the noradrenergic
neurons in the locus coeruleus
and the hypocretin-producing
neurons [13,14] — located exclusively
within a small region of the
hypothalamus — suggest that a
dysfunctional relationship between the
two systems underlies the uncoupling
of muscle tone and arousal that
characterizes cataplexy. Still, despite
all these suggestive links, the
hypothesis that the noradrenergic
system (which comprises the locus
coeruleus and several additional
brainstem structures) is a key player in
cataplexy had not been directly tested,
until now.
Using adult wild-type and hypocretin
knockout mice, Burgess and Peever [2]
first demonstrated that the massetermuscle, a large jaw muscle, exhibits a
sudden loss of muscle tone during
cataplexy. (For the purposes of this
study, the masseter muscle is a
stand-in for all the postural muscles of
the body.) With the loss of muscle tone
established, they then focused their
attention on a group of motoneurons
in the brainstem — trigeminal
motoneurons — that specifically
control the masseter muscle. Similar
to previous elegant studies from this
lab using the trigeminal motor system
[15,16], this was the model system
used for the series of experiments in
this new study.
In order to implicate a particular
subset of adrenergic receptors
(called a1 receptors) in the modulation
of cataplexy, Burgess and Peever [2]
administered drugs systemically to
activate or inhibit these receptors in the
knockout mice. As predicted from
similar experiments in dogs [17] and
humans [18], activating a1 receptors
substantially reduced the incidence
of cataplexy by 90% and inhibiting
these receptors substantially increased
the incidence of cataplexy by 92%.
So far so good. The next step was
to specifically tie these changes
to the motoneurons controlling the
masseter muscle. To do this, they
had to infuse drugs in the vicinity of
the trigeminal motoneurons as
cataplectic episodes occurred. This
was no easy feat as these episodes,
even in hypocretin knockout mice,
are exceedingly rare, normally
occurring only once every several
hours or so. Therefore, it was
necessary to wait patiently for
a cataplectic episode at night (when
they occur more often), at which time
the experimenter infused drugs to
inhibit or activate a1 receptors on
trigeminal motoneurons.
As predicted, before and after a
cataplectic episode when muscle tone
is high, inhibition of a1 receptors
significantly decreased muscle tone; in
contrast, during a cataplectic episode
when muscle tone is already low, the
same drug did not further reduce
muscle tone. Given these results, it
appears that noradrenergic drive to the
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Figure 1. Neural systems linking arousal and motor control in mice.
Behavioral arousal in an awake mouse, as in other mammals, entails the combined activation
of postural muscles and heightened arousal and alertness. Within the brain, the activated
‘motor state’ is supported by brainstem structures that include noradrenergic (NA) cells in
the brainstem (including the locus coeruleus) projecting directly or indirectly to motoneurons
within the brainstem and spinal cord. The heightened ‘arousal state’ is supported by
structures that include the NA neurons in the brainstem, but also hypothalamic neurons
that produce hypocretin (Hcrt) and histamine (HA); these neurons project widely within the
cerebral cortex and are most active during wakefulness. During REM sleep, all of these
systems become less active together. However, during cataplexy, an uncoupling occurs
whereby a heightened arousal state is maintained at the same time as the animal exhibits
a REM-like depressed motor state. Cataplectic episodes are very common in mice lacking
hypocretinergic neurons, due in part to the loss of a functional linkage between them and
noradrenergic neurons in the locus coeruleus (green arrow).
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R835motoneurons is high before and after a
cataplectic episode, but drops to low
or minimal levels during an episode.
However, because pharmacological
inhibition of noradrenergic activity did
not reducemassetermuscle tone to the
same low paralysis-like levels as occur
during cataplexy, other neurochemical
systems must also be involved. Still,
the prominent role of the noradrenergic
system is clear.
Having shown that noradrenergic
drive to trigeminal motoneurons is
reduced during cataplexy, the next
step was to show that increasing
noradrenergic drive to these
motoneurons during cataplexy is
sufficient to restore muscle tone. To do
this, the experimenter waited patiently
as before for instances of cataplexy, at
which time he selectively activated a1
receptors on trigeminal motoneurons.
Again as predicted, muscle tone in the
masseter muscle, upon adrenergic
activation, increased substantially from
the low-tone levels of cataplexy to
levels similar to those seen during
waking. Separately, the authors also
showed that a1-receptor activation
of trigeminal motoneurons similarly
increased muscle tone during REM
sleep, once again highlighting the
similar mechanisms underlying low
muscle tone in both REM sleep and
cataplexy.
All together, these experiments help
us to better understand how a
mismatch can occur in the control of
motor and arousal systems. With
cataplexy, the muscle atonia of REM
sleep and the cognitive awareness
of waking are invoked simultaneously,
because the brain structures that
typically tie muscle activity and
awareness together have become
less stable (whether due to the
neurodegeneration of hypocretin cells
in narcoleptics or the absence of
hypocretin neurons, beginning early
in development [19], in knockout mice).
As Burgess and Peever [2] suggest,
their study ‘‘provides a new framework
for understanding how the
noradrenergic system controls
normal physiology and behavior.’’
Future work will need to address the
interactions of the noradrenergic
and hypocretinergic systems
before, during, and after cataplectic
episodes.
When I give lectures about sleep,
most of the questions I receive concern
phenomena that reside at the ‘edges’:
Is sleepwalking more like walking inyour sleep or sleeping while walking?
If you open your eyes in the morning to
discover you are frozen with paralysis,
are you more awake or asleep? Is
cataplexy a motor disorder of waking
or a cognitive disorder of sleeping?
The ambiguity presented by these
conditions is fascinating and troubling.
Our attempts to resolve these
questions with words alone can
feel more like a philosophical
discussion — ‘‘Is a chair with only
three legs still a chair?’’ — than a
scientific one. Although under most
circumstances our definitions of
sleep and wake serve us well, their
occasional failure reminds us that we
should not be searching for essences
of sleep and wake, but rather
striving to understand these states
as collections of components
[20] — components that typicallycohere but sometimes do not.
Therefore, the best way to resolve
the ambiguity posed by cataplexy
and other similar phenomena is to
leave the world of words and dive
into the actual mechanisms involved.
The wonderfully precise and
technically challenging experiments
of Burgess and Peever [2] do exactly
this by further dissecting the
mechanisms underlying the ambiguity
posed by cataplexy, namely, the
point of interaction between systems
governing muscle control and
behavioral arousal. Therefore, with
cataplexy, the rare but very real
separability of two critical features
of waking life has opened an avenue
of research that is revolutionizing
how we think about the most basic
mammalian experiences of movement
and awareness.
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of Neuronal Replay during SleepPatterns of neuronal activity present during learning in the hippocampus are
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neurophysiological phenomenon by showing that neuronal replay is critical for
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As we sleep, facts, events and skills
learnt during the day continue to be
processed. Our memories become
enhanced, stabilized and integrated
with older memories, a process known
as consolidation [1–3]. The biological
mechanisms underlying memory
consolidation remain poorly
understood. Over forty years ago,
David Marr [4] suggested that while
we sleep, memories formed during
the day may be replayed within the
hippocampus, the part of our brain
involved in memory formation. A
new study [5] reported in this issue
of Current Biology has sought to
determine whether there is a critical
connection between hippocampal
replay and memory consolidation.In a recent series of innovative
studies, sensory cues were used to
reactivate memories during a night
of sleep [6–8]. In one such study,
participants learnt to associate
object-locations with the odor of
rose-petals. During sleep, specifically
during slow wave sleep (SWS),
participants were exposed to either an
odorless vehicle or to the rose-petal
odor they were exposed to while
awake. In the morning, participants
were better able to recall
object-locations if the rose-petal
odor had been applied during the
night compared to the odorless,
control group. Furthermore,
participants underwent functional
brain imaging while in SWS and indeed,
hippocampal activity increased during
odor presentation. These findings
demonstrate that the odor was ableto reactivate, and thereby strengthen
hippocampal-dependent memories [6].
Subsequent studies have gone on to
demonstrate that memory reactivation
can occur through the use of auditory
cues. Various object-locations, each
associated with characteristic sounds,
were more accurately recalled if their
associated sound was played during
SWS [7]. Thus, auditory cues were able
to selectively strengthen individual
memories. Now, Fuentemilla and
colleagues [5] have used auditory cues
to reactivate memories during sleep in
groups of patients, to test for a critical
contribution of the hippocampus to
memory reactivation and
consolidation.
In this study [5], patients with chronic
temporal lobe epilepsy, with damage
restricted to the hippocampus,
were tested in a memory reactivation
task. Three groups of individuals
were studied: those with unilateral
hippocampal sclerosis; those with
bilateral hippocampal sclerosis; and a
healthy age-matched control group. On
the first night, participants learned a list
of 28words, each of which was cued by
an unrelated, unique sound. A sound
was played and then a word would
appear in one of four locations on a
